CLINICAL_TRIALS
trial_result
· 2020-11-05
Clinical Trial Update: Stem Cell Injection in Cancer Survivors [Phase 1]
Summary
Phase 1 trial investigating stem cell injection for cardiomyopathy due to anthracycline exposure in cancer survivors completed with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: The University of Texas Health Science Center, Houston | Conditions: Cardiomyopathy Due to Anthracyclines | Phase 1 | Status: COMPLETED | Results posted: 2020-11-05